-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
- Inhibikase Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -351 %, a 270% decline year-over-year.
- Inhibikase Therapeutics, Inc. annual Return On Equity for 2023 was -108 %, a 63.4% decline from 2022.
- Inhibikase Therapeutics, Inc. annual Return On Equity for 2022 was -65.8 %, a 52.2% decline from 2021.
- Inhibikase Therapeutics, Inc. annual Return On Equity for 2021 was -43.3 %, a 119% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)